Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 3/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.53 |
| ▸ | DRD2 | P14416 | 3/20 | 0.53 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.53 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.48 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | UBE2N | P61088 | 1/20 | 0.47 |
| ▸ | CCR2 | P41597 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10897189 | 0.98 | HTR7 (0.55) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL684347 | 0.88 | LMNA (0.67) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL684013 | 0.87 | HTR1A (0.69) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL683634 | 0.86 | HTR7 (0.67) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL10896398 | 0.85 | LMNA (0.67) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL10896463 | 0.85 | RXFP1 (0.60) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL10896210 | 0.85 | HTR1A (0.67) | HTR7HTR6HTR1ACHRM1DRD2 | |
| SCHEMBL684348 | 0.84 | SMN1; SMN2 (0.69) | HTR7HTR6HTR1ACHRM1DRD2 | |
| Hydrochloric Acid SCHEMBL10896818 | 0.83 | SMN1; SMN2 (0.68) | HTR7HTR6HTR1ACHRM1DRD2 | |
| Hydrochloric Acid SCHEMBL10899529 | 0.83 | SMN1; SMN2 (0.68) | HTR7HTR6HTR1ACHRM1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | BRAINCELLS INC. (US) | 2011-11-03 | — | — | US | disclosed |
| US-4599414-A | ANTHISTAMINES, VASODILATORS | EISAI CO., LTD. (JP) | 1986-07-08 | — | — | US | disclosed |
| EP-0023350-A1 | Theophylline derivatives, a process for the preparation of the same and a therapeutical composition | Eisai Co., Ltd. (JP) | 1981-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | NGF, DCX, BDNF | HTR7 1398/4885HTR6 683/4885HTR1A 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.